2. Anti-infection Metabolic Enzyme/Protease
  3. Bacterial Parasite Endogenous Metabolite
  4. Paromomycin

Paromomycin (Aminosidine) is an orally active broad-spectrum aminoglycoside aminocyclitol. Paromomycin is produced by Streptomyces riomosus var. Paromomycinus. Paromomycin binding induces local conformational changes in the 16S rRNA A-site. Paromomycin exhibits inhibitory activity against C. parvum. Paromomycin can be used in research related to leishmaniasis, amoebiasis and cryptosporidiosis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Paromomycin

Paromomycin 構造式

CAS 番号 : 7542-37-2

容量 在庫状況
50 mg   お問い合わせ  
100 mg   お問い合わせ  
250 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Other 在庫あり Forms of Paromomycin:

Other Forms of Paromomycin:

Paromomycin 関連抗体

Top Publications Citing Use of Products

Parasite アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
Amebae Coccidia Leishmania Mite Plasmodium Toxoplasma Trypanosoma Schistosome

Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
Human Endogenous Metabolite Microbial Metabolite

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Paromomycin (Aminosidine) is an orally active broad-spectrum aminoglycoside aminocyclitol. Paromomycin is produced by Streptomyces riomosus var. Paromomycinus. Paromomycin binding induces local conformational changes in the 16S rRNA A-site. Paromomycin exhibits inhibitory activity against C. parvum. Paromomycin can be used in research related to leishmaniasis, amoebiasis and cryptosporidiosis[1][2][3].

IC50 & Target[1]

Microbial Metabolite

 

Leishmania

 

Amebae

 

Cellular Effect
Cell Line Type Value Description References
HCT-8 IC50
711 nM
Compound: Paromomycin
Antimicrobial activity against Cryptosporidium parvum infected in human HCT-8 cells after 48 hrs by ELISA
Antimicrobial activity against Cryptosporidium parvum infected in human HCT-8 cells after 48 hrs by ELISA
[PMID: 18591280]
J774.A1 CC50
53.33 μg/mL
Compound: Paromomycin
Cytotoxicity against mouse J774A1 cells by MTT assay
Cytotoxicity against mouse J774A1 cells by MTT assay
[PMID: 21295472]
Peritoneal macrophage cell IC50
> 100 μM
Compound: paromomycin
Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay
Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay
[PMID: 22989363]
RAW264.7 IC50
> 100 μM
Compound: paromomycin
Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay
Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay
[PMID: 22989363]
Vero CC50
53.3 μM
Compound: Paromomycin
Cytotoxicity against african green monkey vero cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against african green monkey vero cells assessed as cell viability after 72 hrs by MTT assay
[PMID: 23673014]
体外実験

Paromomycin inhibits Cryptosporidium parvum infection of the differentiated human enterocyte cell line HT29.74[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Paromomycin 関連抗体
体内実験

Paromomycin (1-2 g/kg/day; p.o.; 10 consecutive days) reduces C. parvum infection in immunosuppressed adult C57BL/6N mice, as demonstrated by significant reductions in fecal oocyst shedding (P < 0.01), parasite colonization (P < 0.05), and villus atrophy (P < 0.05) in the ilea and terminal ilea[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6N (female, 6 weeks old, 14-16 g, immunosuppressed with dexamethasone phosphate, infected with Cryptosporidium parvum)[3]
Dosage: 0.25 g/kg/day; 0.5 g/kg/day; 1 g/kg/day; 2 g/kg/day
Administration: p.o.; once daily; 10 consecutive days
Result: Significantly reduced fecal oocyst shedding (P < 0.01) at 1 g/kg/day and 2 g/kg/day, with no rebound after initial reduction.
Significantly lowered parasite colonization in ilea (0.02 ± 0.02 C.
parvum/epithelial cell at 1 g/kg/day; 0 C.
parvum/epithelial cell at 2 g/kg/day) and terminal ilea (0.15 ± 0.08 C.
parvum/epithelial cell at 1 g/kg/day; 0.03 ± 0.03 C.
parvum/epithelial cell at 2 g/kg/day) compared to placebo controls (P < 0.05).
Increased villus-to-crypt (V/C) ratios in ilea (1.99 ± 0.08 at 1 g/kg/day; 1.98 ± 0.02 at 2 g/kg/day) and terminal ilea (1.81 ± 0.11 at 1 g/kg/day; 1.91 ± 0.07 at 2 g/kg/day) compared to placebo controls (P < 0.05), indicating reduced villus atrophy.
Reduced oocyst shedding within 24 hours at 0.25 g/kg/day and 0.5 g/kg/day, but rebound occurred starting on day 14 post-infection with shedding exceeding pretreatment levels.
Showed no significant therapeutic benefit for parasite colonization or villus atrophy relative to placebo controls at 0.25 g/kg/day and 0.5 g/kg/day.
分子量

615.63

分子式

C23H45N5O14
CAS 番号
SMILES

O[C@H]([C@@H]([C@H](O1)CO)O[C@H]2O[C@H]([C@H]([C@@H]([C@H]2N)O)O)CN)[C@@H]1O[C@H]([C@H]([C@@H](C[C@@H]3N)N)O)[C@@H]3O[C@H]4O[C@@H]([C@H]([C@@H]([C@H]4N)O)O)CO
Structure Classification
Initial Source

Streptomyces sp
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Paromomycin Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Paromomycin7542-37-2AminosidineBacterialParasiteEndogenous MetaboliteEntamoeba histolyticaCryptosporidium parvumLeishmania species30S ribosomal subunitHT29.7416S ribosomal RNAC57BL/6N miceDientamoeba fragilisGiardia lamblialeishmaniasisInhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Paromomycin
製品番号:
HY-B0956A
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.